To print this article, all you need is to be registered or login on Mondaq.com.
Matthew Gardella explains why "fallen angel" reverse
mergers have become an attractive alternative to the traditional
IPO for privately held life sciences companies looking to go
public.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
Starting your own business involves many decisions, from choosing the right corporate structure to allocating equity. Proper planning is crucial for building success...
When the U.S. Supreme Court's June 2023 decision in Students for Fair Admissions, Inc. significantly curtailed race-based affirmative action in higher education...
The Corporate Transparency Act (CTA), 31 U.S.C. §5336, became effective on January 1, 2024. Under this new provision, if your or your client's entity is a "reporting company,"...